100 related articles for article (PubMed ID: 26784362)
21. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
Fukushima T; Ueda T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
[TBL] [Abstract][Full Text] [Related]
22. Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
Arlin ZA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():57-9. PubMed ID: 2653519
[No Abstract] [Full Text] [Related]
23. [Treatment of acute myelogenous leukemia].
Ono R
Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1040-5. PubMed ID: 1383364
[No Abstract] [Full Text] [Related]
24. Treating the elderly patient with acute myelogenous leukemia.
Luger SM
Hematology Am Soc Hematol Educ Program; 2010; 2010():62-9. PubMed ID: 21239772
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic Transplantation for Acute Myelogenous Leukemia in CR1.
Estey E
Biol Blood Marrow Transplant; 2018 Feb; 24(2):205-206. PubMed ID: 29248740
[No Abstract] [Full Text] [Related]
26. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
[No Abstract] [Full Text] [Related]
27. Donor leukocyte infusions in acute myelogenous leukemia.
Porter DL
Leukemia; 2003 Jun; 17(6):1035-7. PubMed ID: 12764364
[No Abstract] [Full Text] [Related]
28. [Assessment of the therapeutic effect in acute myelogenous leukemia].
Pu Q
Zhonghua Nei Ke Za Zhi; 1993 Oct; 32(10):653-5. PubMed ID: 8156832
[No Abstract] [Full Text] [Related]
29. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
Suciu S; Solbu G; Zittoun R; Hayat M; Willemze R; de Witte T; Mandelli F
Bone Marrow Transplant; 1991; 7 Suppl 2():34. PubMed ID: 1878707
[No Abstract] [Full Text] [Related]
30. High dose cytarabine in acute myelogenous leukemia.
Zittoun R
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
[No Abstract] [Full Text] [Related]
31. Treatment of acute myelogenous leukemia.
Estey EH
Oncology (Williston Park); 2002 Mar; 16(3):343-52, 355-6; discussion 357, 362, 365-6. PubMed ID: 15046392
[TBL] [Abstract][Full Text] [Related]
32. Leukemia cutis in a patient with acute myelogenous leukemia: a case report and review of the literature.
Aguilera SB; Zarraga M; Rosen L
Cutis; 2010 Jan; 85(1):31-6. PubMed ID: 20184209
[TBL] [Abstract][Full Text] [Related]
33. Why is clinical progress in acute myelogenous leukemia so slow?
Rowe JM
Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-3. PubMed ID: 18342806
[No Abstract] [Full Text] [Related]
34. Chemotherapy of acute myelogenous leukemia. A review.
Zittoun R
Leukemia; 1992; 6 Suppl 2():36-8. PubMed ID: 1578939
[No Abstract] [Full Text] [Related]
35. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute myelogenous leukemia in the elderly.
Champlin RE; Gajewski JL; Golde DW
Semin Oncol; 1989 Feb; 16(1):51-6. PubMed ID: 2645650
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous remission in acute myelogenous leukemia: a case report.
Gau JP; Young JH; Lin TH; Yang Y; Ho KC
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Feb; 59(2):121-5. PubMed ID: 9175302
[TBL] [Abstract][Full Text] [Related]
38. What is the best induction regimen for acute myelogenous leukemia?
Rowe JM
Leukemia; 1998 Sep; 12 Suppl 1():S16-9. PubMed ID: 9777889
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of acute myelogenous leukemia in elderly patients].
Wierzbowska A; Robak T
Pol Arch Med Wewn; 2001; 105 Suppl():385-9. PubMed ID: 12412273
[No Abstract] [Full Text] [Related]
40. [Recent advance on chemotherapy of leukemia].
Nakamura T; Ueda T
Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1531-7. PubMed ID: 7798745
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
